Paper39028490
Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.
Yang L and 7 others. Inflamm Res, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma. Papers, record 39028490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39028490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroblastoma | Major topic |
| Tumor Necrosis Factor alpha-Induced Protein 3 | Major topic |
| Biomarkers, Tumor | Major topic |
| Humans | |
| Prognosis | |
| Gene Expression Profiling | |
| Transcriptome | |
| Tumor-Associated Macrophages | |
| Tumor Escape | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 2018YFC1313004 | the Ministry of Science and Technology of the People's Republic of China | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36054452 | Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/36054452 | PubMed |
| 2 | 24202395 | Microenvironmental regulation of tumor progression and metastasis. | Nat Med | 2013 | https://conductscience.org/library/papers/24202395 | PubMed |
| 3 | 28117416 | Tumour-associated macrophages as treatment targets in oncology. | Nat Rev Clin Oncol | 2017 | https://conductscience.org/library/papers/28117416 | PubMed |
| 4 | 22704353 | Clinico-pathological significance of TNF alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal carcinoma. | Clin Epigenetics | 2011 | https://conductscience.org/library/papers/22704353 | PubMed |
| 5 | 30545920 | Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma. | Cancer Res | 2019 | https://conductscience.org/library/papers/30545920 | PubMed |
| 6 | 29797634 | Clinical significance of MYCN amplification in patients with high-risk neuroblastoma. | Pediatr Blood Cancer | 2018 | https://conductscience.org/library/papers/29797634 | PubMed |
| 7 | 26080408 | COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26080408 | PubMed |
| 8 | 16609014 | Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16609014 | PubMed |
| 9 | 31810498 | Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31810498 | PubMed |
| 10 | 26538215 | A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression. | Mol Cancer | 2015 | https://conductscience.org/library/papers/26538215 | PubMed |
| 11 | 33933552 | The dual roles of A20 in cancer. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33933552 | PubMed |
| 12 | 35525858 | Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma. | Genes Immun | 2022 | https://conductscience.org/library/papers/35525858 | PubMed |
| 13 | 26304901 | Advances in Risk Classification and Treatment Strategies for Neuroblastoma. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26304901 | PubMed |
| 14 | 27425378 | Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development. | J Pathol | 2016 | https://conductscience.org/library/papers/27425378 | PubMed |
| 15 | 30776148 | Monocyte heterogeneity and functions in cancer. | J Leukoc Biol | 2019 | https://conductscience.org/library/papers/30776148 | PubMed |
| 16 | 25386934 | Neuroblastoma: molecular pathogenesis and therapy. | Annu Rev Med | 2015 | https://conductscience.org/library/papers/25386934 | PubMed |
| 17 | 37246217 | IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37246217 | PubMed |
| 18 | 29755120 | Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29755120 | PubMed |
| 19 | 19411762 | Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19411762 | PubMed |
| 20 | 22927533 | Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22927533 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40682067 | Single-cell RNA sequencing technology was employed to construct a risk prediction model for genes associated with pyroptosis and ferroptosis in lung adenocarcinoma. | Respir Res | 2025 | https://conductscience.org/library/papers/40682067 | PubMed |
| 39915361 | Identification of IFI27 involvement in the progression of neuroblastoma through bioinformatics analysis and experimental assays. | J Mol Histol | 2025 | https://conductscience.org/library/papers/39915361 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNFAIP3 | 7128 | PubTator's text mining | https://conductscience.org/library/genes/7128 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39028490
GET https://conductscience.org/api/papers/v1/39028490/references?page=2